Gene · 4824
Papers3,429
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,429
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Distant Metastases of an Atypical Meningioma 14 Years Later After Primary Tumor Resection: A Case Report and Review of the Literature. | Case Rep Pathol | 2026 | 41755809 | PubTator, text mining | PubMed |
| Clinicogenomic Insights for Progression-Free Survival in Prostate Cancer. | Int J Environ Res Public Health | 2026 | 41752338 | PubTator, text mining | PubMed |
| The Mystery of the Hidden Trace: Emerging Genetic Approaches to Improve Body Fluid Identification. | Genes (Basel) | 2026 | 41751530 | PubTator, text mining | PubMed |
| CDX2 Expression and Fluoropyrimidine Response in Rare Non-GI Tumors: A Three-Case Series. | Curr Oncol | 2026 | 41744890 | PubTator, text mining | PubMed |
| Molecular mechanisms and classification of castration-resistant prostate cancer: Insights into androgen receptor, cancer stem cells, and neuroendocrine features. | Curr Urol | 2026 | 41743916 | PubTator, text mining | PubMed |
| Genetic and epigenetic mechanisms underlying treatment-induced neuroendocrine prostate cancer. | J Natl Cancer Cent | 2026 | 41738035 | PubTator, text mining | PubMed |
| Transcriptional and epigenetic reprogramming, lineage plasticity and therapy resistance in prostate cancer. | J Natl Cancer Cent | 2026 | 41738031 | PubTator, text mining | PubMed |
| Metastatic castrate-resistant prostate cancer to the penis resulting in malignant priapism and urethral obstruction. | Urol Case Rep | 2026 | 41737673 | PubTator, text mining | PubMed |
| Anti-hyperplastic effects of Acmella oleracea flower and leaf extracts in prostate cell lines and in spontaneously hypertensive rats. | J Mol Histol | 2026 | 41729335 | PubTator, text mining | PubMed |
| Assessing the effects of a 3D pathology tissue-processing workflow on downstream molecular analyses. | bioRxiv | 2026 | 41726900 | PubTator, text mining | PubMed |
| Renal-Type Clear Cell Carcinoma of the Prostate: A Histopathological Case Report of a Rare and Underrecognized Variant. | Reports (MDPI) | 2026 | 41718313 | PubTator, text mining | PubMed |
| A high-grade undifferentiated prostate malignancy in a young male suggestive of male adnexal tumour of Wolffian origin - A rare case and diagnostic challenge. | Urol Case Rep | 2026 | 41716524 | PubTator, text mining | PubMed |
| Robust and efficient annotation of cell states through gene signature scoring. | Genome Res | 2026 | 41708334 | PubTator, text mining | PubMed |
| Development of a Late-Stage Functionalization Strategy to Access Diverse 3,5-Disubstituted 1,2,4-Thiadiazoles. | J Org Chem | 2026 | 41697074 | PubTator, text mining | PubMed |
| Remarkable Response to Etoposide and Cisplatin in Aggressive-Variant Prostate Cancer With Low Prostate-Specific Antigen Levels: A Case Report. | Cureus | 2026 | 41640939 | PubTator, text mining | PubMed |
| Gene Regulatory Programs of NK Cells Show That NCAM1 (CD56) and KIRs Are Controlled by Genetically Polymorphic Distal Regulatory Elements. | Eur J Immunol | 2026 | 41636199 | PubTator, text mining | PubMed |
| Androgen Receptor Positive EWSR1::FEV-Rearranged Prostatic Ewing Sarcoma Mimicking High-Grade Neuroendocrine Carcinoma. | Int J Surg Pathol | 2026 | 41632692 | PubTator, text mining | PubMed |
| NKX3.1 in the airways: a diagnostic trap in transbronchial fine needle aspirations. | J Am Soc Cytopathol | 2026 | 41582076 | PubTator, text mining | PubMed |
| Fifty Years of Natural Killer Cells: Milestones and Future Horizons. | Scand J Immunol | 2026 | 41580304 | PubTator, text mining | PubMed |
| Progressive Metastatic Cutaneous TFCP2::FUS Fusion-Positive Rhabdomyosarcoma: A Case Report. | Case Rep Oncol | 2026 | 41552649 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4824/papers?page=3